Myosmine
Specifications
532-12-7CAS Number
637-297-7EC Number
3-(3,4-dihydro-2H-pyrrol-5-yl)pyridineIUPAC Name
C9H10N2Chemical Formula
146.19 g/molMolecular Weight
Myosmine; 532-12-7; 3-(3,4-Dihydro-2H-pyrrol-5-yl)pyridine; 3-(1-Pyrrolin-2-yl)pyridine; 2-(3-Pyridyl)-1-pyrroline; Pyridine, 3-(3,4-dihydro-2H-pyrrol-5-yl)-; DTXSID70891866; 9O0A545W4L; CHEBI:7051; RefChem:160358; DTXCID001009059; 637-297-7; MFCD00052019; Miosmine; 3-(1-PYRROLIN-2-YL)-PYRIDINE; 3-(4,5-Dihydro-3H-pyrrol-2-yl)-pyridine; CHEMBL423429; 3-(2-Pyrrolin-2-yl)pyridine; Pyridine, 3-(1-pyrrolin-2-yl)-; s3311; Nicotine EP Impurity D; 3-(4,5-Dihydro-3H-pyrrol-2-yl)pyridine (Myosmine); UNII-9O0A545W4L; CCRIS 9356; Prestwick_202; Myosmine (Standard); Myosmine, 98%; BRN 0119254; Spectrum_001130; SpecPlus_000615; Prestwick0_000647; Prestwick1_000647; Prestwick2_000647; Prestwick3_000647; BSPBio_000653; KBioSS_001610; 5-23-06-00466 (Beilstein Handbook Reference); DivK1c_006711; SPBio_002574; BPBio1_000719; orb1299607; SCHEMBL5319476; SCHEMBL5654756; SCHEMBL29398376; KBio1_001655; KBio2_001610; KBio2_004178; KBio2_006746; US8609708, 79 Myosmine; HMS1570A15; HMS2097A15; HMS5086K14; HY-W001909R; MSK14015; BDBM50125053; 3-(1-Pyrrolin-2-yl)pyridine, 8CI; AKOS005254654; CCG-214475; CS-W001909; FM26110; HY-W001909; NCGC00016493-01; NCGC00016493-02; NCGC00163359-01; AC-35719; CAS-532-12-7; DA-75828; MS-20037; NICOTINE IMPURITY D [EP IMPURITY]; SY076072; 3-(3,4-Dihydro-2H-pyrrol-5-yl)-Pyridine; NS00073889; ST50824026; T7671; 3-(3,4-Dihydro-2H-pyrrol-5-yl)pyridine #; 3-(3,4-Dihydro-2H-pyrrol-5-yl)pyridine, 9CI; 3-(4,5-DIHYDRO-3H-PYRROL-2-YL)PYRIDINE; F475214; NICOTINE RESINATE IMPURITY D [EP IMPURITY]; Q411486; BRD-K67556876-001-03-1; BRD-K67556876-001-04-9; NICOTINE DITARTRATE DIHYDRATE IMPURITY D [EP IMPURITY]Synonyms